![Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d5d7c187-2f1d-4f07-a0dd-825d6633f582/gr1.jpg)
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology
![Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension | Neurology Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension | Neurology](https://n.neurology.org/content/neurology/96/4/e610/F2.large.jpg)
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension | Neurology
![PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/60afa7902fddea770036d6744ee84027545bd238/3-Figure1-1.png)
PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar
![Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial | Scientific Reports Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-81502-2/MediaObjects/41598_2021_81502_Fig1_HTML.png)
Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial | Scientific Reports
![Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study – JCAD | The Journal of Clinical Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study – JCAD | The Journal of Clinical](https://jcadonline.com/wp-content/uploads/PariserNovember2019Fig1.jpg)
Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study – JCAD | The Journal of Clinical
![PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/814ad6ccbfa9defca4d2b00c4672f9070cf6b8da/16-Figure1-1.png)
PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar
![Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/06/clinicaltrials-2-e1566478031946.jpg)
Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals
![Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK546770/bin/clapp7f1.jpg)
Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf
![An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1857-3/MediaObjects/13075_2019_1857_Fig1_HTML.png)
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text
![An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough | European Respiratory Society An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough | European Respiratory Society](https://openres.ersjournals.com/content/erjor/7/3/00447-2021/F1.large.jpg)
An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough | European Respiratory Society
![SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer - European Urology SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c242775c-0dc2-4bd8-b3b5-a076cc5b31c0/gr1_lrg.jpg)
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer - European Urology
![Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)](https://bmjopen.bmj.com/content/bmjopen/5/12/e009562/F1.large.jpg)
Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)
![Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram](https://www.researchgate.net/profile/Wendy-Komocsar/publication/265174624/figure/fig1/AS:267323823095810@1440746374062/Randomized-controlled-trial-and-open-label-extension-study-designs-aNonresponders-20.png)
Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram
![An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13601-017-0172-9/MediaObjects/13601_2017_172_Fig1_HTML.gif)